Market Overview

$1.1 Billion Primary Cells Market by Type, Origin, End User - Global Forecast to 2023

Share:

$1.1 Billion Primary Cells Market by Type, Origin, End User - Global Forecast to 2023

PR Newswire

DUBLIN, Aug 13, 2018 /PRNewswire/ --

The "Primary Cells Market by Type (Human Primary Cells, Animal Primary Cells), Origin (Hematopoietic, Blood, Skin, Gastrointestinal, Hepatocytes, Renal, Skeleton & Muscles), End User (Life Science Research & Research Institutes) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global primary cells market is expected to reach USD 1,107.3 million by 2023 from USD 736.4 million in 2018, at a CAGR of 8.5%.

Growth in the primary cells market is mainly driven by factors such as increasing cancer research; the advantages of primary human cells over cell lines; the increasing demand for monoclonal antibodies; rapid growth in the biotechnology and biopharmaceutical industries, partnerships, collaborations, and acquisitions; and increasing pharmaceutical outsourcing.

The global primary cells market is segmented by origin, type, end user, and region. By origin, the primary cells market is classified into hematopoietic, skin, gastrointestinal, liver, lung, renal, heart, skeletal & muscle, and other primary cells. The liver cells segment is expected to register the highest CAGR during the forecast period due to their increasing demand in toxicological and pharmacological studies.

Based on type, the market is segmented into human and animal primary cells. The human primary cells segment is expected to register the highest CAGR during the forecast period owing to the high adoption of human primary cells in the development of novel cancer therapies. Human primary cells are also extensively used for studying human cancerous cell models, in toxicology studies, and in the cosmetic industry.

On the basis of end user, the market is segmented into life science research companies and research institutes. The life science research companies segment is expected to grow at the highest CAGR during the forecast period. The high growth rate can be attributed to the high adoption of primary cells in cell-based experiments and cancer research in life science research companies as well as the increasing number of R&D facilities globally.

The global primary cells market is dominated by North America, followed by Europe. North America will continue to dominate the global primary cells market during the forecast period, however, Asia is expected to witness the highest CAGR, with the growth in this market centered on China and Japan. Increasing number of players launching new human primary cells for research, expansion of pharmaceutical and biotechnology industries, and increasing prevalence of cancer in the region are the major factors driving the growth of the North American market. However, regulatory concerns regarding primary cell culture contamination will restrain the growth of this market.

Some of the major players in the primary cells market are:

  • Thermo Fisher Scientific
  • Merck KGaA
  • Lonza
  • Cell Biologics
  • PromoCell
  • ZenBio
  • STEMCELL Technologies
  • AllCells
  • American Type Culture Collection
  • Axol Biosciences

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

4.1 Primary Cells: Market Overview
4.2 Primary Cells Market Share, By Region & Origin, 2018
4.3 Primary Cells Market, By Type, 2018-2023 (USD Million)
4.4 Geographical Snapshot of the Primary Cells Market

5 Market Overview

5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Cancer Research
5.2.1.2 Advantages of Primary Human Cells Over Cell Lines
5.2.1.3 Increasing Demand for Monoclonal Antibodies
5.2.1.4 Rapid Growth in the Biotechnology and Biopharmaceutical Industries
5.2.1.5 Partnerships, Collaborations, and Acquisitions Strengthening Market Growth
5.2.1.6 Increasing Pharmaceutical Outsourcing
5.2.2 Restraints
5.2.2.1 Concerns Regarding Primary Cell Culture Contamination
5.2.3 Opportunities
5.2.3.1 Advancing Biomedical Research Using Primary Cells in 3D Culture

6 Primary Cells Market, By Origin

6.1 Introduction
6.2 Hematopoietic Cells
6.3 Skin Cells
6.4 Gastrointestinal Cells
6.5 Liver Cells
6.6 Lung Cells
6.7 Renal Cells
6.8 Heart
6.9 Skeletal and Muscle Cells
6.10 Other Primary Cells

7 Primary Cells Market, By Type

7.1 Introduction
7.2 Human Primary Cells
7.3 Animal Primary Cells

8 Primary Cells Market, By End User

8.1 Introduction
8.2 Life Science Research Companies
8.3 Research Institutes

9 Primary Cells Market, By Region

10 Competitive Landscape

10.1 Overview
10.2 Market Share Ranking, 2017
10.3 Top Ranking Companies in the Primary Cells Market
10.4 Competitive Scenario
10.4.1 Product Launches
10.4.2 Expansions
10.4.3 Acquisitions

11 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/j4vllw/1_1_billion?w=5

Media Contact:


Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 




Cision View original content:http://www.prnewswire.com/news-releases/1-1-billion-primary-cells-market-by-type-origin-end-user---global-forecast-to-2023--300695898.html

SOURCE Research and Markets

View Comments and Join the Discussion!